Notice: This company has been marked as potentially delisted and may not be actively trading. Ariad Pharmaceuticals (ARIA) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair AppointmentOctober 3, 2024 | finance.yahoo.comSolu Therapeutics Strengthens Leadership Team with Appointment of Sergio Santillana, MD, as Chief Medical OfficerSeptember 10, 2024 | finance.yahoo.comAffimed Appoints Shawn Leland As New CEOSeptember 3, 2024 | markets.businessinsider.comTerns Pharmaceuticals Finance Chief Vignola LeavingJuly 29, 2024 | marketwatch.comIDRx Appoints David P. Kerstein, M.D., as Chief Medical OfficerMarch 27, 2024 | finance.yahoo.comIDRx Strengthens Executive Team with Appointments of Tim Clackson, Ph.D., as CEO and Brad Dahms as CFO and CBOMarch 12, 2024 | finance.yahoo.comWhat Is Donanemab? Eli Lilly’s Alzheimer’s Drug Gets Delayed Decision From FDAMarch 8, 2024 | msn.comTakeda extends lease in Kendall Square through 2040March 4, 2024 | bizjournals.comIncyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D PrioritiesFebruary 13, 2024 | finance.yahoo.comVeteran biotech entrepreneur Harvey Berger to lead startup Kojin TherapeuticsJanuary 3, 2024 | msn.comHarvey Berger leaves biotech 'sidelines' for new CEO gigJanuary 3, 2024 | bizjournals.comBiogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's TreatmentOctober 26, 2023 | msn.comLeukemia Therapeutics Treatment Market Set to Achieve US$ 30,318.5 Million by 2033 at 7.1% CAGR | Future Market Insights Inc.October 12, 2023 | benzinga.comKickstarter’s new finance chief is ultra-extroverted—and she credits that trait to her success as a ‘people-centric CFO’September 6, 2023 | fortune.comChronic Lymphocytic Leukemia Treatment Global Market Report 2023August 24, 2023 | finance.yahoo.comAriad Stock Falls On Unusually High Volume (ARIA)August 20, 2023 | thestreet.comSecond Alzheimer’s drug to slow disease’s progression may be approved in the US this yearJuly 19, 2023 | msn.comSecond Alzheimer's drug to slow disease's progression may be approved in the US this yearJuly 17, 2023 | cbsnews.comSarissa Capital Urges Alkermes Shareholders to Vote "FOR" Sarah Schlesinger and "WITHHOLD" Incumbent Director Richard GaynorJune 28, 2023 | finance.yahoo.comActivist Pro Tip: Don’t Put Your Girlfriend on the BoardJune 26, 2023 | washingtonpost.comPonatinib Market Research | 2023-2030May 17, 2023 | marketwatch.comComprehensive Analysis of Cancer Treatment Drugs Market Trends and Growth 2023-2030May 16, 2023 | marketwatch.comIclusig Market Research | 2023-2030May 14, 2023 | marketwatch.comUterine Cancer Therapies and Diagnostic Market Forecast 2023-2030May 10, 2023 | marketwatch.comThe Global Targeted Drugs for NSCLC Market Size is expanding rapidly, with a CAGR of 12.2% from 2023 to 2030May 5, 2023 | marketwatch.comChronic Myeloid Leukemia (CML) Treatment Market 2023 [New Report forecast 2030] Current and Future TrendsMay 5, 2023 | marketwatch.comEli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also RisesMay 3, 2023 | msn.comAcute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Analysis and Forecast to 2031May 3, 2023 | marketwatch.comCancer Drugs Market Applications and Types with Regional Analysis 2023-2031May 3, 2023 | marketwatch.comStomach Cancer Drugs Market (2023-2030) Rivalry Heats Up with New CAGR StatusApril 28, 2023 | marketwatch.comGlobal Gastric Cancer Drugs Market Report 2023: Increasing Number of Obesity Cases and the Smoking Population Drives GrowthApril 20, 2023 | benzinga.com2023-2030 Chronic Myeloid Leukemia (CML) Treatment Market Size with ManufacturesApril 20, 2023 | marketwatch.com2023-2030 Ponatinib Market Size Detailed Report with Downstream Market Analysis | Research by Absolute ReportsApril 19, 2023 | marketwatch.comUnlock Vital Data on Ponatinib market: Financial Summary, Shareholding Patterns, and Revenue Mix with Predicted CAGR of 5.1% from 2023-2030April 12, 2023 | marketwatch.comChronic Myeloid Leukemia (CML) Treatment Market 2023 Size and Forecast to 2031April 9, 2023 | marketwatch.comIn-depth Cancer Treatment Drugs report provides key estimates for predicting a projected CAGR of 5.2%April 8, 2023 | marketwatch.comPonatinib Market Research Analysis 2023-2030April 7, 2023 | marketwatch.comBile Duct Cancer Drug Market Growing Demand and Trends 2023 to 2031March 29, 2023 | marketwatch.comAnti-Cancer Drug Market Size and Forecast till 2031March 27, 2023 | marketwatch.comGlobal Cancer Drugs Market 2023 Projection, Growth Rate and Emerging Trends Analysis to 2030 By VMReportsMarch 26, 2023 | marketwatch.comIclusig Market Top Players and Forecast till 2031March 22, 2023 | marketwatch.comPonatinib Market Size 2023 to 2028 By Deployment, Growth Factor and Production costMarch 14, 2023 | marketwatch.comThe Evolution of Bile Duct Cancer Drug Market 2023: Future Developments and Trends by 2028March 11, 2023 | marketwatch.com2023-2029 Anti-Cancer Drug Market Size and Latest Trends Analysis | Research Report by Absolute ReportsMarch 10, 2023 | marketwatch.comGrowth Analysis on Proto-Oncogene Drgu Market Size 2023-2028 with Prominent Manufacturers | Research Report by Absolute ReportsMarch 8, 2023 | marketwatch.comForecasting the Future of Chronic Myeloid Leukemia (CML) Treatment Market: Analysing Emerging Trends and Opportunities 2023-2028March 7, 2023 | marketwatch.comGlobal Targeted Drug EGFR RTK Inhibitors for NSCLC Market Opportunities, Business Statistics Research Report 2030 By VMReportsMarch 4, 2023 | marketwatch.comGlobal Targeted Drugs for NSCLC Market Size Analysis, Share, Application, Opportunities Forecast to 2030 By VMReportsMarch 4, 2023 | marketwatch.comGlobal Anti-Cancer Drug Market 2023 Industry Share, Analysis of Competitive Landscape and Forecast 2030 By VMReportsMarch 4, 2023 | marketwatch.comGlobal Acute Lymphocytic / Lymphoblastic Leukemia Drugs Market Upcoming Trends, Opportunities by Types and Application to 2030 By VMReportsMarch 1, 2023 | marketwatch.com Get Ariad Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW ARIA Media Mentions By Week ARIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARIA News Sentiment▼0.000.57▲Average News Sentiment ARIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARIA Articles This Week▼00▲ARIA Articles Average Week Get Ariad Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Vertex Pharmaceuticals News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARIA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ariad Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ariad Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
